Board Change • May 18
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Henrik Elmin was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • May 05
First quarter 2026 earnings released: EPS: kr1.47 (vs kr1.75 in 1Q 2025) First quarter 2026 results: EPS: kr1.47 (down from kr1.75 in 1Q 2025). Revenue: kr4.77b (down 11% from 1Q 2025). Net income: kr507.0m (down 16% from 1Q 2025). Profit margin: 11% (in line with 1Q 2025). Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Italy. Board Change • May 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Director Nils-Johan Andersson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 12
Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024) Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.5% growth forecast for the Chemicals industry in Italy. Reported Earnings • Jan 30
Full year 2025 earnings released: EPS: kr5.64 (vs kr6.45 in FY 2024) Full year 2025 results: EPS: kr5.64 (down from kr6.45 in FY 2024). Revenue: kr19.3b (down 5.4% from FY 2024). Net income: kr1.94b (down 13% from FY 2024). Profit margin: 10% (in line with FY 2024). Revenue is forecast to stay flat during the next 3 years compared to a 6.9% growth forecast for the Chemicals industry in Italy. Reported Earnings • Oct 27
Third quarter 2025 earnings released: EPS: kr1.35 (vs kr1.62 in 3Q 2024) Third quarter 2025 results: EPS: kr1.35 (down from kr1.62 in 3Q 2024). Revenue: kr4.69b (down 5.7% from 3Q 2024). Net income: kr465.0m (down 17% from 3Q 2024). Profit margin: 9.9% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years compared to a 7.7% growth forecast for the Chemicals industry in Italy. お知らせ • Sep 22
Hexpol AB (Publ) Announces President Changes for Hexpol Compounding Americas, Effective September 19, 2025 HEXPOL AB (publ) has appointed Kenneth Bloom as interim President of HEXPOL Compounding Americas effective September 19, 2025. Kenneth Bloom succeeds Gary Moore, who will leave the company September 19, 2025. Kenneth Bloom will act as interim President until a permanent successor has been appointed. Kenneth has previously held the position as President of HEXPOL Compounding Americas between 2020 and 2022 and before that has some 20 years of experience within the polymer industry. Reported Earnings • Jul 20
Second quarter 2025 earnings released: EPS: kr1.56 (vs kr1.90 in 2Q 2024) Second quarter 2025 results: EPS: kr1.56 (down from kr1.90 in 2Q 2024). Revenue: kr5.00b (down 8.4% from 2Q 2024). Net income: kr537.0m (down 18% from 2Q 2024). Profit margin: 11% (down from 12% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy. お知らせ • Jun 17
HEXPOL AB (publ) to Report Q4, 2025 Results on Jan 29, 2026 HEXPOL AB (publ) announced that they will report Q4, 2025 results on Jan 29, 2026 お知らせ • May 01
HEXPOL AB (publ) (OM:HPOL B) acquired 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler. HEXPOL AB (publ) (OM:HPOL B) has signed an agreement to acquire 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler for €54 million on February 18, 2025. The acquisition price amounts to 54 MEUR on a cash and debt free basis and is funded by a combination of bank facilities and cash. The closing will take place after regulatory approvals. HEXPOL has an option toacquire the remaining shares, and the founders have an option to sell their remaining shares to HEXPOL. For the period ending December 31, 2024, KABKOM Kimya Sanayi ve Ticaret A.S. reported total revenue of €30 million.
HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of 80% stake in Kabkom Kimya Sanayi ve Ticaret Anonim Sirketi form Erdem Eker, Özgür Ipek and Bekir Güler on April 30, 2025. お知らせ • Apr 26
Hexpol AB (Publ) Approves Dividend for Financial Year 2024 HEXPOL AB (publ) at its AGM held on April 25, 2025, resolved in accordance with the proposal of the Board of Directors that a dividend of SEK 4.20 per share be declared for the financial year 2024 and that the accumulated earnings be carried forward. The record date for the dividend shall be April 29, 2025. お知らせ • Apr 10
HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta. HEXPOL AB (publ) (OM:HPOL B) acquired remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025. In line with the communication at the time of acquisition of almaak in 2022, the option to purchase the remaining 30% of almaak is now exercised. Current management will remain with the company. The transaction takes place on 9 April 2025 and will be included in the second quarter of 2025.
HEXPOL AB (publ) (OM:HPOL B) completed the acquisition of remaining 30% stake in almaak international GmbH from Olaf Eichstädt and Thomas Schmeinta on April 9, 2025. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €8.14, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 12x in the Chemicals industry in Europe. Simply Wall St's valuation model estimates the intrinsic value at €15.88 per share. Reported Earnings • Mar 26
Full year 2024 earnings released: EPS: kr6.45 (vs kr7.33 in FY 2023) Full year 2024 results: EPS: kr6.45 (down from kr7.33 in FY 2023). Revenue: kr20.4b (down 7.3% from FY 2023). Net income: kr2.22b (down 12% from FY 2023). Profit margin: 11% (in line with FY 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Italy. お知らせ • Jan 29
HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025 HEXPOL AB (publ), Annual General Meeting, Apr 25, 2025. Location: malmo Sweden